0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Luteinizing Hormone-releasing Hormone Analogs Drugs Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-22H10516
Home | Market Reports | Health| Reproductive Health
Global and United States Luteinizing Hormone releasing Hormone Analogs Drugs Market Report Forecast 2022 2028
BUY CHAPTERS

Global Luteinizing Hormone-releasing Hormone Analogs Drugs Market Research Report 2024

Code: QYRE-Auto-22H10516
Report
June 2024
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Luteinizing Hormone-releasing Hormone Analogs Drugs Market Size

The global Luteinizing Hormone-releasing Hormone Analogs Drugs market was valued at US$ 4152 million in 2023 and is anticipated to reach US$ 4576.3 million by 2030, witnessing a CAGR of 1.3% during the forecast period 2024-2030.

Luteinizing Hormone-releasing Hormone Analogs Drugs Market

Luteinizing Hormone-releasing Hormone Analogs Drugs Market

Luteinizing Hormone-releasing Hormone is a releasing hormone responsible for the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the anterior pituitary. 
The Luteinizing Hormone-releasing Hormone (LHRH) Analogs market is primarily driven by the demand for hormone therapy options in managing hormone-dependent conditions such as prostate cancer and certain gynecological disorders. LHRH analogs, also known as LHRH agonists, are medications that suppress the release of sex hormones by altering the signaling of the hypothalamus-pituitary-gonadal axis. The increasing prevalence of hormone-related diseases, coupled with advancements in oncology and reproductive medicine, contributes to market growth. Moreover, the demonstrated benefits of LHRH analogs in reducing hormone levels and controlling tumor growth further propel adoption. However, challenges include optimizing treatment regimens for specific conditions and addressing potential side effects such as hormonal imbalances and bone density loss. Navigating personalized treatment plans, managing patient expectations, and ensuring long-term safety and efficacy are ongoing concerns. The market's success relies on continuous research in endocrinology and oncology, collaborations between pharmaceutical manufacturers and healthcare providers, and comprehensive patient education on the benefits and potential risks of LHRH analog treatments while addressing the evolving challenges associated with hormone-related diseases and treatment customization.
This report aims to provide a comprehensive presentation of the global market for Luteinizing Hormone-releasing Hormone Analogs Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Luteinizing Hormone-releasing Hormone Analogs Drugs.

Report Scope

The Luteinizing Hormone-releasing Hormone Analogs Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Luteinizing Hormone-releasing Hormone Analogs Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Luteinizing Hormone-releasing Hormone Analogs Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Luteinizing Hormone-releasing Hormone Analogs Drugs Market Report

Report Metric Details
Report Name Luteinizing Hormone-releasing Hormone Analogs Drugs Market
Accounted market size in 2023 US$ 4152 million
Forecasted market size in 2030 US$ 4576.3 million
CAGR 1.3%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Leuprorelin
  • Goserelin
  • Taltirelin
  • Histrelin
  • Other
Segment by Application
  • Hospital
  • Pharmacy
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AbbVie, AstraZeneca, Ferring, TerSera Therapeutics, Takeda, LIVZON, Ipsen, Sanofi, Endo
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Luteinizing Hormone-releasing Hormone Analogs Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Luteinizing Hormone-releasing Hormone Analogs Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Luteinizing Hormone-releasing Hormone Analogs Drugs Market growing?

Ans: The Luteinizing Hormone-releasing Hormone Analogs Drugs Market witnessing a CAGR of 1.3% during the forecast period 2024-2030.

What is the Luteinizing Hormone-releasing Hormone Analogs Drugs Market size in 2030?

Ans: The Luteinizing Hormone-releasing Hormone Analogs Drugs Market size in 2030 will be US$ 4576.3 million.

Who are the main players in the Luteinizing Hormone-releasing Hormone Analogs Drugs Market report?

Ans: The main players in the Luteinizing Hormone-releasing Hormone Analogs Drugs Market are AbbVie, AstraZeneca, Ferring, TerSera Therapeutics, Takeda, LIVZON, Ipsen, Sanofi, Endo

What are the Application segmentation covered in the Luteinizing Hormone-releasing Hormone Analogs Drugs Market report?

Ans: The Applications covered in the Luteinizing Hormone-releasing Hormone Analogs Drugs Market report are Hospital, Pharmacy, Other

What are the Type segmentation covered in the Luteinizing Hormone-releasing Hormone Analogs Drugs Market report?

Ans: The Types covered in the Luteinizing Hormone-releasing Hormone Analogs Drugs Market report are Leuprorelin, Goserelin, Taltirelin, Histrelin, Other

1 Luteinizing Hormone-releasing Hormone Analogs Drugs Market Overview
1.1 Product Overview and Scope of Luteinizing Hormone-releasing Hormone Analogs Drugs
1.2 Luteinizing Hormone-releasing Hormone Analogs Drugs Segment by Type
1.2.1 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Leuprorelin
1.2.3 Goserelin
1.2.4 Taltirelin
1.2.5 Histrelin
1.2.6 Other
1.3 Luteinizing Hormone-releasing Hormone Analogs Drugs Segment by Application
1.3.1 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Market Size Estimates and Forecasts
1.4.1 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue 2019-2030
1.4.2 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales 2019-2030
1.4.3 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Luteinizing Hormone-releasing Hormone Analogs Drugs Market Competition by Manufacturers
2.1 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Luteinizing Hormone-releasing Hormone Analogs Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Luteinizing Hormone-releasing Hormone Analogs Drugs, Product Type & Application
2.7 Luteinizing Hormone-releasing Hormone Analogs Drugs Market Competitive Situation and Trends
2.7.1 Luteinizing Hormone-releasing Hormone Analogs Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Luteinizing Hormone-releasing Hormone Analogs Drugs Players Market Share by Revenue
2.7.3 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Luteinizing Hormone-releasing Hormone Analogs Drugs Retrospective Market Scenario by Region
3.1 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Region: 2019-2030
3.2.1 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Region: 2019-2024
3.2.2 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Region: 2025-2030
3.3 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Region: 2019-2030
3.3.1 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Region: 2019-2024
3.3.2 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Region: 2025-2030
3.4 North America Luteinizing Hormone-releasing Hormone Analogs Drugs Market Facts & Figures by Country
3.4.1 North America Luteinizing Hormone-releasing Hormone Analogs Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Country (2019-2030)
3.4.3 North America Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Luteinizing Hormone-releasing Hormone Analogs Drugs Market Facts & Figures by Country
3.5.1 Europe Luteinizing Hormone-releasing Hormone Analogs Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Country (2019-2030)
3.5.3 Europe Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Luteinizing Hormone-releasing Hormone Analogs Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Luteinizing Hormone-releasing Hormone Analogs Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Luteinizing Hormone-releasing Hormone Analogs Drugs Market Facts & Figures by Country
3.7.1 Latin America Luteinizing Hormone-releasing Hormone Analogs Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Country (2019-2030)
3.7.3 Latin America Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Luteinizing Hormone-releasing Hormone Analogs Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Luteinizing Hormone-releasing Hormone Analogs Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Type (2019-2030)
4.1.1 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Type (2019-2024)
4.1.2 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Type (2025-2030)
4.1.3 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Share by Type (2019-2030)
4.2 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Type (2019-2030)
4.2.1 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Type (2019-2024)
4.2.2 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Type (2025-2030)
4.2.3 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Application (2019-2030)
5.1.1 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Application (2019-2024)
5.1.2 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Application (2025-2030)
5.1.3 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Share by Application (2019-2030)
5.2 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Application (2019-2030)
5.2.1 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Application (2019-2024)
5.2.2 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Application (2025-2030)
5.2.3 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Luteinizing Hormone-releasing Hormone Analogs Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Luteinizing Hormone-releasing Hormone Analogs Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AbbVie Luteinizing Hormone-releasing Hormone Analogs Drugs Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Luteinizing Hormone-releasing Hormone Analogs Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AstraZeneca Luteinizing Hormone-releasing Hormone Analogs Drugs Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Ferring
6.3.1 Ferring Corporation Information
6.3.2 Ferring Description and Business Overview
6.3.3 Ferring Luteinizing Hormone-releasing Hormone Analogs Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Ferring Luteinizing Hormone-releasing Hormone Analogs Drugs Product Portfolio
6.3.5 Ferring Recent Developments/Updates
6.4 TerSera Therapeutics
6.4.1 TerSera Therapeutics Corporation Information
6.4.2 TerSera Therapeutics Description and Business Overview
6.4.3 TerSera Therapeutics Luteinizing Hormone-releasing Hormone Analogs Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 TerSera Therapeutics Luteinizing Hormone-releasing Hormone Analogs Drugs Product Portfolio
6.4.5 TerSera Therapeutics Recent Developments/Updates
6.5 Takeda
6.5.1 Takeda Corporation Information
6.5.2 Takeda Description and Business Overview
6.5.3 Takeda Luteinizing Hormone-releasing Hormone Analogs Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Takeda Luteinizing Hormone-releasing Hormone Analogs Drugs Product Portfolio
6.5.5 Takeda Recent Developments/Updates
6.6 LIVZON
6.6.1 LIVZON Corporation Information
6.6.2 LIVZON Description and Business Overview
6.6.3 LIVZON Luteinizing Hormone-releasing Hormone Analogs Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 LIVZON Luteinizing Hormone-releasing Hormone Analogs Drugs Product Portfolio
6.6.5 LIVZON Recent Developments/Updates
6.7 Ipsen
6.6.1 Ipsen Corporation Information
6.6.2 Ipsen Description and Business Overview
6.6.3 Ipsen Luteinizing Hormone-releasing Hormone Analogs Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ipsen Luteinizing Hormone-releasing Hormone Analogs Drugs Product Portfolio
6.7.5 Ipsen Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Corporation Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Luteinizing Hormone-releasing Hormone Analogs Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sanofi Luteinizing Hormone-releasing Hormone Analogs Drugs Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Endo
6.9.1 Endo Corporation Information
6.9.2 Endo Description and Business Overview
6.9.3 Endo Luteinizing Hormone-releasing Hormone Analogs Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Endo Luteinizing Hormone-releasing Hormone Analogs Drugs Product Portfolio
6.9.5 Endo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Luteinizing Hormone-releasing Hormone Analogs Drugs Industry Chain Analysis
7.2 Luteinizing Hormone-releasing Hormone Analogs Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Luteinizing Hormone-releasing Hormone Analogs Drugs Production Mode & Process
7.4 Luteinizing Hormone-releasing Hormone Analogs Drugs Sales and Marketing
7.4.1 Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Channels
7.4.2 Luteinizing Hormone-releasing Hormone Analogs Drugs Distributors
7.5 Luteinizing Hormone-releasing Hormone Analogs Drugs Customers
8 Luteinizing Hormone-releasing Hormone Analogs Drugs Market Dynamics
8.1 Luteinizing Hormone-releasing Hormone Analogs Drugs Industry Trends
8.2 Luteinizing Hormone-releasing Hormone Analogs Drugs Market Drivers
8.3 Luteinizing Hormone-releasing Hormone Analogs Drugs Market Challenges
8.4 Luteinizing Hormone-releasing Hormone Analogs Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Luteinizing Hormone-releasing Hormone Analogs Drugs Average Price (USD/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Luteinizing Hormone-releasing Hormone Analogs Drugs, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Luteinizing Hormone-releasing Hormone Analogs Drugs, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Luteinizing Hormone-releasing Hormone Analogs Drugs, Product Type & Application
    Table 12. Global Key Manufacturers of Luteinizing Hormone-releasing Hormone Analogs Drugs, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Luteinizing Hormone-releasing Hormone Analogs Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Luteinizing Hormone-releasing Hormone Analogs Drugs as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Region (2019-2024) & (K Units)
    Table 18. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Share by Region (2019-2024)
    Table 19. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Region (2025-2030) & (K Units)
    Table 20. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Share by Region (2025-2030)
    Table 21. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Market Share by Region (2019-2024)
    Table 23. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Market Share by Region (2025-2030)
    Table 25. North America Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Country (2019-2024) & (K Units)
    Table 27. North America Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Country (2025-2030) & (K Units)
    Table 28. North America Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Drugs Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales (K Units) by Type (2019-2024)
    Table 51. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales (K Units) by Type (2025-2030)
    Table 52. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Share by Type (2019-2024)
    Table 53. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Share by Type (2025-2030)
    Table 54. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Market Share by Type (2019-2024)
    Table 57. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Market Share by Type (2025-2030)
    Table 58. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Price (USD/Unit) by Type (2019-2024)
    Table 59. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Price (USD/Unit) by Type (2025-2030)
    Table 60. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales (K Units) by Application (2019-2024)
    Table 61. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales (K Units) by Application (2025-2030)
    Table 62. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Share by Application (2019-2024)
    Table 63. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Share by Application (2025-2030)
    Table 64. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Market Share by Application (2019-2024)
    Table 67. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Market Share by Application (2025-2030)
    Table 68. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Price (USD/Unit) by Application (2019-2024)
    Table 69. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Price (USD/Unit) by Application (2025-2030)
    Table 70. AbbVie Corporation Information
    Table 71. AbbVie Description and Business Overview
    Table 72. AbbVie Luteinizing Hormone-releasing Hormone Analogs Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 73. AbbVie Luteinizing Hormone-releasing Hormone Analogs Drugs Product
    Table 74. AbbVie Recent Developments/Updates
    Table 75. AstraZeneca Corporation Information
    Table 76. AstraZeneca Description and Business Overview
    Table 77. AstraZeneca Luteinizing Hormone-releasing Hormone Analogs Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 78. AstraZeneca Luteinizing Hormone-releasing Hormone Analogs Drugs Product
    Table 79. AstraZeneca Recent Developments/Updates
    Table 80. Ferring Corporation Information
    Table 81. Ferring Description and Business Overview
    Table 82. Ferring Luteinizing Hormone-releasing Hormone Analogs Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 83. Ferring Luteinizing Hormone-releasing Hormone Analogs Drugs Product
    Table 84. Ferring Recent Developments/Updates
    Table 85. TerSera Therapeutics Corporation Information
    Table 86. TerSera Therapeutics Description and Business Overview
    Table 87. TerSera Therapeutics Luteinizing Hormone-releasing Hormone Analogs Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 88. TerSera Therapeutics Luteinizing Hormone-releasing Hormone Analogs Drugs Product
    Table 89. TerSera Therapeutics Recent Developments/Updates
    Table 90. Takeda Corporation Information
    Table 91. Takeda Description and Business Overview
    Table 92. Takeda Luteinizing Hormone-releasing Hormone Analogs Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 93. Takeda Luteinizing Hormone-releasing Hormone Analogs Drugs Product
    Table 94. Takeda Recent Developments/Updates
    Table 95. LIVZON Corporation Information
    Table 96. LIVZON Description and Business Overview
    Table 97. LIVZON Luteinizing Hormone-releasing Hormone Analogs Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 98. LIVZON Luteinizing Hormone-releasing Hormone Analogs Drugs Product
    Table 99. LIVZON Recent Developments/Updates
    Table 100. Ipsen Corporation Information
    Table 101. Ipsen Description and Business Overview
    Table 102. Ipsen Luteinizing Hormone-releasing Hormone Analogs Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 103. Ipsen Luteinizing Hormone-releasing Hormone Analogs Drugs Product
    Table 104. Ipsen Recent Developments/Updates
    Table 105. Sanofi Corporation Information
    Table 106. Sanofi Description and Business Overview
    Table 107. Sanofi Luteinizing Hormone-releasing Hormone Analogs Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 108. Sanofi Luteinizing Hormone-releasing Hormone Analogs Drugs Product
    Table 109. Sanofi Recent Developments/Updates
    Table 110. Endo Corporation Information
    Table 111. Endo Description and Business Overview
    Table 112. Endo Luteinizing Hormone-releasing Hormone Analogs Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 113. Endo Luteinizing Hormone-releasing Hormone Analogs Drugs Product
    Table 114. Endo Recent Developments/Updates
    Table 115. Key Raw Materials Lists
    Table 116. Raw Materials Key Suppliers Lists
    Table 117. Luteinizing Hormone-releasing Hormone Analogs Drugs Distributors List
    Table 118. Luteinizing Hormone-releasing Hormone Analogs Drugs Customers List
    Table 119. Luteinizing Hormone-releasing Hormone Analogs Drugs Market Trends
    Table 120. Luteinizing Hormone-releasing Hormone Analogs Drugs Market Drivers
    Table 121. Luteinizing Hormone-releasing Hormone Analogs Drugs Market Challenges
    Table 122. Luteinizing Hormone-releasing Hormone Analogs Drugs Market Restraints
    Table 123. Research Programs/Design for This Report
    Table 124. Key Data Information from Secondary Sources
    Table 125. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Luteinizing Hormone-releasing Hormone Analogs Drugs
    Figure 2. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Market Share by Type in 2023 & 2030
    Figure 4. Leuprorelin Product Picture
    Figure 5. Goserelin Product Picture
    Figure 6. Taltirelin Product Picture
    Figure 7. Histrelin Product Picture
    Figure 8. Other Product Picture
    Figure 9. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 10. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Market Share by Application in 2023 & 2030
    Figure 11. Hospital
    Figure 12. Pharmacy
    Figure 13. Other
    Figure 14. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Market Size (2019-2030) & (US$ Million)
    Figure 16. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales (2019-2030) & (K Units)
    Figure 17. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Average Price (USD/Unit) & (2019-2030)
    Figure 18. Luteinizing Hormone-releasing Hormone Analogs Drugs Report Years Considered
    Figure 19. Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Share by Manufacturers in 2023
    Figure 20. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Share by Manufacturers in 2023
    Figure 21. The Global 5 and 10 Largest Luteinizing Hormone-releasing Hormone Analogs Drugs Players: Market Share by Revenue in 2023
    Figure 22. Luteinizing Hormone-releasing Hormone Analogs Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 23. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 24. North America Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Share by Country (2019-2030)
    Figure 25. North America Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Market Share by Country (2019-2030)
    Figure 26. United States Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. Canada Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. Europe Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Share by Country (2019-2030)
    Figure 29. Europe Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Market Share by Country (2019-2030)
    Figure 30. Germany Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. France Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. U.K. Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Italy Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Russia Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Asia Pacific Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Share by Region (2019-2030)
    Figure 36. Asia Pacific Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Market Share by Region (2019-2030)
    Figure 37. China Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Japan Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. South Korea Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. India Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Australia Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. China Taiwan Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Indonesia Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Thailand Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Malaysia Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Latin America Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Share by Country (2019-2030)
    Figure 47. Latin America Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Market Share by Country (2019-2030)
    Figure 48. Mexico Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Brazil Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Argentina Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Share by Country (2019-2030)
    Figure 52. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Market Share by Country (2019-2030)
    Figure 53. Turkey Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. UAE Luteinizing Hormone-releasing Hormone Analogs Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 56. Global Sales Market Share of Luteinizing Hormone-releasing Hormone Analogs Drugs by Type (2019-2030)
    Figure 57. Global Revenue Market Share of Luteinizing Hormone-releasing Hormone Analogs Drugs by Type (2019-2030)
    Figure 58. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Price (USD/Unit) by Type (2019-2030)
    Figure 59. Global Sales Market Share of Luteinizing Hormone-releasing Hormone Analogs Drugs by Application (2019-2030)
    Figure 60. Global Revenue Market Share of Luteinizing Hormone-releasing Hormone Analogs Drugs by Application (2019-2030)
    Figure 61. Global Luteinizing Hormone-releasing Hormone Analogs Drugs Price (USD/Unit) by Application (2019-2030)
    Figure 62. Luteinizing Hormone-releasing Hormone Analogs Drugs Value Chain
    Figure 63. Luteinizing Hormone-releasing Hormone Analogs Drugs Production Process
    Figure 64. Channels of Distribution (Direct Vs Distribution)
    Figure 65. Distributors Profiles
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS